AbbVie Expands Psychiatric Drug Prospects, Inking R&D Pact With Neuroscience Startup
MedCity News
MAY 14, 2024
AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications. The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better side effect profile.
Let's personalize your content